Sort
17,828 grants matching “crispr”
Nucleic Acid-Based Anti-CRISPR Inhibitors of Cas9
$269,720Keith Thomas Gagnon · Southern Illinois University Carbondale · R01 · FY2022 · GM
Nucleic Acid-Based Anti-CRISPR Inhibitors of Cas9
$269,720Keith Thomas Gagnon · Southern Illinois University Carbondale · R01 · FY2021 · GM
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach
$269,601Cesar M Castro · Massachusetts General Hospital · U01 · FY2025 · CA
Genomic Instability and Cancer Genetics
$269,566Chang S Chan · Rutgers Biomedical And Health Sciences · P30 · FY2025 · CA
Oncogenic mechanisms and molecular targets in myeloma
$269,362Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Core C - Genomics, CRISPR, and Gene Perturbation Core
$269,332E. John Wherry · University Of Pittsburgh At Pittsburgh · P01 · FY2025 · AI
Structures of RNA processing and Silencing Enzymes in Prokaryotes
$269,317Hong Li · Florida State University · R01 · FY2012 · GM
Discovering the mechanisms-of-action of mistargeted anti-cancer agents
$269,280Jason Sheltzer · Cold Spring Harbor Laboratory · R01 · FY2020 · CA
Elucidating the function of PAX3-FOXO1 in rhabdomyosarcoma with molecular reporters and next-generation genome editing
$269,280Christopher Vakoc · Cold Spring Harbor Laboratory · R21 · FY2020 · CA
Identify novel modulators of regulatory T cell function from the dynamic cis-proteomes
$269,250Yongqiang Feng · St. Jude Children'S Research Hospital · R21 · FY2021 · AI
Novel targeted therapies for chronic myelomonocytic leukemia
$269,244Roger Vincent Belizaire · Dana-Farber Cancer Inst · K08 · FY2025 · CA
Novel targeted therapies for chronic myelomonocytic leukemia
$269,244Roger Vincent Belizaire · Dana-Farber Cancer Inst · K08 · FY2024 · CA
Novel targeted therapies for chronic myelomonocytic leukemia
$269,244Roger Vincent Belizaire · Dana-Farber Cancer Inst · K08 · FY2022 · CA
Novel targeted therapies for chronic myelomonocytic leukemia
$269,244Roger Vincent Belizaire · Dana-Farber Cancer Inst · K08 · FY2023 · CA
Defining the role of KEAP/NRF2 signaling dysregulation and sensory nerve reprograming during acquisition of cisplatin resistance and metastasis in HNSCC
$269,157Abdullah Ali Osman · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
Animal Models to Study Plague Infection and Immunity
$269,055B J Hinnebusch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Expression Genetics of CYP3A Drug Metabolizing Enzymes
$269,004Danxin Wang · University Of Florida · R01 · FY2019 · GM
CRISPR tools to dissect the coding and non-coding genome
$269,000Joana Vidigal · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Defining the role of GNAS in gastrointestinal metastasis
$268,826Michael Foote · Sloan-Kettering Inst Can Research · K08 · FY2023 · CA
Defining the role of GNAS in gastrointestinal metastasis
$268,826Michael Foote · Sloan-Kettering Inst Can Research · K08 · FY2025 · CA
Defining the role of GNAS in gastrointestinal metastasis
$268,826Michael Foote · Sloan-Kettering Inst Can Research · K08 · FY2024 · CA
Understanding the Healthy Gut Virome and its Role in Human Health
$268,780Mark J Young · Montana State University - Bozeman · R01 · FY2018 · GM
Understanding the Healthy Gut Virome and its Role in Human Health
$268,780Mark J Young · Montana State University - Bozeman · R01 · FY2017 · GM
Understanding the Healthy Gut Virome and its Role in Human Health
$268,780Mark J Young · Montana State University - Bozeman · R01 · FY2019 · GM
Modeling Heterogenous Outcomes in Functional Genetic Screens Using Single-cell Genomics as Readouts
$268,752Wei Li · Children'S Research Institute · R01 · FY2023 · HG